Tumor Microenvironment‐Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference and Redox Catalysis
Advanced Science · 2026
DOI: 10.1002/advs.76146 ↗At a glance
Journal article in Advanced Science, 2026. Written by Rui Fu and 10 co-authors. Institution: Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China. Major MEDLINE topics: Disulfidptosis, Pancreatic Neoplasms, Tumor Microenvironment. Cited 1 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: Suzhou Science and Technology Key Research Program of Medical and Health Innovation Project, Suzhou Fundamental Research Project, USTC Biomedical Engineering Fusion Foundation.
Abstract (original language)
Pancreatic cancer exhibits extensive metabolic reprogramming that supports rapid progression and therapeutic resistance, making metabolic vulnerabilities attractive targets for intervention. Here, a tumor microenvironment‐responsive nanoreactor (Pht@HMnO 2 ‐HA) is designed to induce disulfidptosis in pancreatic cancer through coordinated metabolic interference and redox catalysis. Following CD44‐mediated tumor targeting and cellular internalization, the nanoreactor's responsive self‐optimization within the tumor microenvironment enables localized release of phloretin, suppressing glucose uptake and pentose phosphate pathway activity and thereby limiting intracellular reducing‐power generation. In parallel, the nanoreactor consumes intracellular glutathione and amplifies oxidative stress via MnO 2 ‐mediated redox reactions, thereby depleting antioxidant defenses. Together, these processes impose reducing‐power deprivation and disrupt redox homeostasis, leading to cystine accumulation, disulfide stress, actin cytoskeleton collapse, and disulfidptosis in pancreatic cancer cells. Moreover, degradation‐associated Mn 2 + release provides activatable T1‐weighted MRI contrast, enabling noninvasive visualization of intratumoral nanoreactor activation and therapeutic progression. Collectively, this work establishes a theranostic nanoreactor that exploits coupled metabolic and redox vulnerabilities to induce disulfidptosis, offering a mechanistically grounded strategy for precision therapy in pancreatic cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow Universi…
- Department of Interventional Radiology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, Suzhou, China.
ORCID profiles: Liqiang Qin, Yu Chong
Funding
- Suzhou Science and Technology Key Research Program of Medical and Health Innovation Project
- Suzhou Fundamental Research Project
- USTC Biomedical Engineering Fusion Foundation
- Key Laboratory of Radiation Damage and Treatment of Jiangsu Provincial Universities and Colleges
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Cite
APA
Fu, R., Li, Q., Zhao, G., Gao, Q., Chen, H., Hidayat, K., Xu, J., Qin, L., Hu, C., Chong, Y., & Hu, S. (2026). Tumor Microenvironment‐Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference and Redox Catalysis. Advanced Science. https://doi.org/10.1002/advs.76146
Vancouver
Fu R, Li Q, Zhao G, Gao Q, Chen H, Hidayat K, et al. Tumor Microenvironment‐Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference and Redox Catalysis. Advanced Science. 2026. doi:10.1002/advs.76146
BibTeX
@article{Fu2026,
author = {Fu, Rui and Li, Qing and Zhao, Guanzhong and Gao, Qingyan and Chen, Huantong and Hidayat, Khemayanto and Xu, Jiaying and Qin, Liqiang and Hu, Chunhong and Chong, Yu and Hu, Su},
title = {Tumor Microenvironment‐Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference and Redox Catalysis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76146}
}
EUVIMED